Preface

Jyotsna Batra; Srilakshmi Srinivasan

doi:10.1007/978-1-4939-9769-5

Preface

Jyotsna Batra
, Srilakshmi Srinivasan

Research output: Chapter in Book/Report/Conference proceeding › Foreword/postscript › Research › peer-review

Abstract

The term “theranostics” implies to a combination of therapy and diagnostics and has been used by scientific community in a variety of contexts. Over the past decade, the field of theranostics has advanced considerably with respect to advances in biomarker identification, new molecular imaging probes, genetics and high-throughput techniques, imaging-guided molecular therapy, and new nanotheranostics. The field is appropriate to explain the advancement in science to establish accurate and personalized therapies for various diseases and to combine diagnostic and therapeutic applications into a single agent for the development of a promising paradigm involving diagnosis, drug delivery, and monitoring of disease
response to treatment.

Original language	English
Title of host publication	Theranostics: Methods and Protocols
Publisher	Springer Nature
Pages	v - vii
Number of pages	3
Volume	2054
ISBN (Electronic)	9781493997695
ISBN (Print)	9781493997688
DOIs	https://doi.org/10.1007/978-1-4939-9769-5
Publication status	Published - 1 Jan 2019
Externally published	Yes

Publication series

Name	Methods in Molecular Biology
Publisher	Humana Press Inc.
ISSN (Print)	1064-3745
ISSN (Electronic)	1940-6029

Access to Document

10.1007/978-1-4939-9769-5

Cite this

@inbook{b51720e350904b27bd2adec90858ebe4,

title = "Preface",

abstract = "The term “theranostics” implies to a combination of therapy and diagnostics and has been used by scientific community in a variety of contexts. Over the past decade, the field of theranostics has advanced considerably with respect to advances in biomarker identification, new molecular imaging probes, genetics and high-throughput techniques, imaging-guided molecular therapy, and new nanotheranostics. The field is appropriate to explain the advancement in science to establish accurate and personalized therapies for various diseases and to combine diagnostic and therapeutic applications into a single agent for the development of a promising paradigm involving diagnosis, drug delivery, and monitoring of disease response to treatment.",

author = "Jyotsna Batra and Srilakshmi Srinivasan",

year = "2019",

month = jan,

day = "1",

doi = "10.1007/978-1-4939-9769-5",

language = "English",

isbn = "9781493997688",

volume = "2054",

series = "Methods in Molecular Biology",

publisher = "Springer Nature",

pages = "v -- vii",

booktitle = "Theranostics: Methods and Protocols",

}

TY - CHAP

T1 - Preface

AU - Batra, Jyotsna

AU - Srinivasan, Srilakshmi

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The term “theranostics” implies to a combination of therapy and diagnostics and has been used by scientific community in a variety of contexts. Over the past decade, the field of theranostics has advanced considerably with respect to advances in biomarker identification, new molecular imaging probes, genetics and high-throughput techniques, imaging-guided molecular therapy, and new nanotheranostics. The field is appropriate to explain the advancement in science to establish accurate and personalized therapies for various diseases and to combine diagnostic and therapeutic applications into a single agent for the development of a promising paradigm involving diagnosis, drug delivery, and monitoring of disease response to treatment.

AB - The term “theranostics” implies to a combination of therapy and diagnostics and has been used by scientific community in a variety of contexts. Over the past decade, the field of theranostics has advanced considerably with respect to advances in biomarker identification, new molecular imaging probes, genetics and high-throughput techniques, imaging-guided molecular therapy, and new nanotheranostics. The field is appropriate to explain the advancement in science to establish accurate and personalized therapies for various diseases and to combine diagnostic and therapeutic applications into a single agent for the development of a promising paradigm involving diagnosis, drug delivery, and monitoring of disease response to treatment.

UR - https://www.scopus.com/pages/publications/85072080736

U2 - 10.1007/978-1-4939-9769-5

DO - 10.1007/978-1-4939-9769-5

M3 - Foreword/postscript

AN - SCOPUS:85072080736

SN - 9781493997688

VL - 2054

T3 - Methods in Molecular Biology

SP - v - vii

BT - Theranostics: Methods and Protocols

PB - Springer Nature

ER -

Preface

Abstract

Publication series

Access to Document

Other files and links

Fingerprint

Cite this